Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?

•Bone single photon emission computed tomography/computed tomography (SPECT/CT) can identify infection sites.•The effectiveness of bone SPECT/CT in identifying optimal sites for microbiological sampling remains under-explored.•We investigated whether bone SPECT/CT can effectively guide microbiologic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Injury 2024-12, Vol.55 (12), p.111940, Article 111940
Hauptverfasser: Lee, Seung Hoo, Kim, Min Bom, Jeon, Yeong June
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page 111940
container_title Injury
container_volume 55
creator Lee, Seung Hoo
Kim, Min Bom
Jeon, Yeong June
description •Bone single photon emission computed tomography/computed tomography (SPECT/CT) can identify infection sites.•The effectiveness of bone SPECT/CT in identifying optimal sites for microbiological sampling remains under-explored.•We investigated whether bone SPECT/CT can effectively guide microbiological sampling in osteomyelitis of the extremities.•The results demonstrated that bone SPECT/CT is a valuable tool for identifying optimal microbiological sampling sites.•Bone SPECT/CT is particularly effective when antibiotics have been discontinued for ≥2 weeks. Accurate microbiological identification is crucial when managing chronic osteomyelitis (COM) and post-traumatic osteomyelitis (PTO). Although bone single photon emission computed tomography/computed tomography (SPECT/CT) has helped in localizing osteomyelitis lesions, its effectiveness in guiding microbiological sampling remains unclear. This study aimed to determine whether bone SPECT/CT can improve microbiological identification rates in COM or PTO of the extremities. From February 2020 to August 2024, 53 patients with suspected COM or PTO in the extremities were retrospectively analyzed. All patients underwent bone SPECT/CT, followed by microbiological sampling during surgery. Tissue samples were taken from the areas of high SPECT/CT uptake or based on intraoperative findings where no uptake was observed. Microorganism identification rates were analyzed, including a sub-group analysis based on antibiotic discontinuation. Of the 53 patients, 42 had positive bone SPECT/CT scan findings, with pathogen identification in 30 patients (71.4 %). In contrast, pathogen identification occurred in one out of twelve patients (9.1 %) with negative findings (odds ratio 25, p< 0.001). Bone SPECT/CT demonstrated a sensitivity of 96.8 % and an overall accuracy of 75.5 %. When antibiotics had been discontinued for ≥2 weeks, the pathogen identification rate increased to 90 %, compared with 50 % for
doi_str_mv 10.1016/j.injury.2024.111940
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3118470775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0020138324006697</els_id><sourcerecordid>3118470775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-93cf90384d17231b96b114ca9ff1e062a602f4f355ab58653b8f295c0e9380d03</originalsourceid><addsrcrecordid>eNp9UU2P1DAMjRCIHRb-AUI5cumsnaRfFxCqlg9pJZAYzlGbOpBR2wxJumJ-AX-bjLpw5GT7-T1b9mPsJcIeAaub494txzWc9wKE2iNiq-AR22FTtwWIqn7MdgACCpSNvGLPYjwCYA1SPmVXslWiwgp37HfXL3zwC_GvX267w0134CMlCrPLkD8lN_cTjy5R5NYHPjsT_OD85L87kztupCU5m_Pk_MLdwk8-piKFfp0zZHjWmB_BL5c0JvLzmSaXXOTecvqVAs25ovj2OXti-ynSi4d4zb69vz10H4u7zx8-de_uCiMUpqKVxrYgGzViLSQObTUgKtO31iJBJfoKhFVWlmU_lE1VyqGxoi0NUCsbGEFes9fb3FPwP1eKSc8uGpqmfiG_Ri0RG1VDXZeZqjZqPjnGQFafQn5HOGsEfbFAH_Vmgb5YoDcLsuzVw4Z1mGn8J_r780x4sxEo33nvKOhoHC2GRhfIJD169_8NfwAYC5tk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3118470775</pqid></control><display><type>article</type><title>Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lee, Seung Hoo ; Kim, Min Bom ; Jeon, Yeong June</creator><creatorcontrib>Lee, Seung Hoo ; Kim, Min Bom ; Jeon, Yeong June</creatorcontrib><description>•Bone single photon emission computed tomography/computed tomography (SPECT/CT) can identify infection sites.•The effectiveness of bone SPECT/CT in identifying optimal sites for microbiological sampling remains under-explored.•We investigated whether bone SPECT/CT can effectively guide microbiological sampling in osteomyelitis of the extremities.•The results demonstrated that bone SPECT/CT is a valuable tool for identifying optimal microbiological sampling sites.•Bone SPECT/CT is particularly effective when antibiotics have been discontinued for ≥2 weeks. Accurate microbiological identification is crucial when managing chronic osteomyelitis (COM) and post-traumatic osteomyelitis (PTO). Although bone single photon emission computed tomography/computed tomography (SPECT/CT) has helped in localizing osteomyelitis lesions, its effectiveness in guiding microbiological sampling remains unclear. This study aimed to determine whether bone SPECT/CT can improve microbiological identification rates in COM or PTO of the extremities. From February 2020 to August 2024, 53 patients with suspected COM or PTO in the extremities were retrospectively analyzed. All patients underwent bone SPECT/CT, followed by microbiological sampling during surgery. Tissue samples were taken from the areas of high SPECT/CT uptake or based on intraoperative findings where no uptake was observed. Microorganism identification rates were analyzed, including a sub-group analysis based on antibiotic discontinuation. Of the 53 patients, 42 had positive bone SPECT/CT scan findings, with pathogen identification in 30 patients (71.4 %). In contrast, pathogen identification occurred in one out of twelve patients (9.1 %) with negative findings (odds ratio 25, p&lt; 0.001). Bone SPECT/CT demonstrated a sensitivity of 96.8 % and an overall accuracy of 75.5 %. When antibiotics had been discontinued for ≥2 weeks, the pathogen identification rate increased to 90 %, compared with 50 % for &lt;2 weeks of discontinuation (odds ratio 10.0, p= 0.006). In a sub-group of 30 patients with adequate antibiotic discontinuation duration, a positive bone SPECT/CT scan yielded a pathogen identification rate of 90.1 % (odds ratio 60.0, p= 0.001). Bone SPECT/CT effectively identifies optimal sites for microbiological sampling in COM and PTO of the extremities, particularly when antibiotics have been discontinued for ≥2 weeks, enhancing pathogen detection rates.</description><identifier>ISSN: 0020-1383</identifier><identifier>ISSN: 1879-0267</identifier><identifier>EISSN: 1879-0267</identifier><identifier>DOI: 10.1016/j.injury.2024.111940</identifier><identifier>PMID: 39426161</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - therapeutic use ; Antibiotic discontinuation ; Bone SPECT/CT scan ; Chronic Disease ; Chronic osteomyelitis (COM) ; Extremities - diagnostic imaging ; Extremities - microbiology ; Female ; Humans ; Male ; Microbiological identification ; Middle Aged ; Osteomyelitis - diagnosis ; Osteomyelitis - diagnostic imaging ; Osteomyelitis - microbiology ; Pathogen detection ; Post-traumatic osteomyelitis (PTO) ; Retrospective Studies ; Sensitivity and Specificity ; Single Photon Emission Computed Tomography Computed Tomography ; Young Adult</subject><ispartof>Injury, 2024-12, Vol.55 (12), p.111940, Article 111940</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-93cf90384d17231b96b114ca9ff1e062a602f4f355ab58653b8f295c0e9380d03</cites><orcidid>0000-0001-8260-4358 ; 0009-0003-9382-9116 ; 0000-0001-8335-9331</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.injury.2024.111940$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39426161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Seung Hoo</creatorcontrib><creatorcontrib>Kim, Min Bom</creatorcontrib><creatorcontrib>Jeon, Yeong June</creatorcontrib><title>Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?</title><title>Injury</title><addtitle>Injury</addtitle><description>•Bone single photon emission computed tomography/computed tomography (SPECT/CT) can identify infection sites.•The effectiveness of bone SPECT/CT in identifying optimal sites for microbiological sampling remains under-explored.•We investigated whether bone SPECT/CT can effectively guide microbiological sampling in osteomyelitis of the extremities.•The results demonstrated that bone SPECT/CT is a valuable tool for identifying optimal microbiological sampling sites.•Bone SPECT/CT is particularly effective when antibiotics have been discontinued for ≥2 weeks. Accurate microbiological identification is crucial when managing chronic osteomyelitis (COM) and post-traumatic osteomyelitis (PTO). Although bone single photon emission computed tomography/computed tomography (SPECT/CT) has helped in localizing osteomyelitis lesions, its effectiveness in guiding microbiological sampling remains unclear. This study aimed to determine whether bone SPECT/CT can improve microbiological identification rates in COM or PTO of the extremities. From February 2020 to August 2024, 53 patients with suspected COM or PTO in the extremities were retrospectively analyzed. All patients underwent bone SPECT/CT, followed by microbiological sampling during surgery. Tissue samples were taken from the areas of high SPECT/CT uptake or based on intraoperative findings where no uptake was observed. Microorganism identification rates were analyzed, including a sub-group analysis based on antibiotic discontinuation. Of the 53 patients, 42 had positive bone SPECT/CT scan findings, with pathogen identification in 30 patients (71.4 %). In contrast, pathogen identification occurred in one out of twelve patients (9.1 %) with negative findings (odds ratio 25, p&lt; 0.001). Bone SPECT/CT demonstrated a sensitivity of 96.8 % and an overall accuracy of 75.5 %. When antibiotics had been discontinued for ≥2 weeks, the pathogen identification rate increased to 90 %, compared with 50 % for &lt;2 weeks of discontinuation (odds ratio 10.0, p= 0.006). In a sub-group of 30 patients with adequate antibiotic discontinuation duration, a positive bone SPECT/CT scan yielded a pathogen identification rate of 90.1 % (odds ratio 60.0, p= 0.001). Bone SPECT/CT effectively identifies optimal sites for microbiological sampling in COM and PTO of the extremities, particularly when antibiotics have been discontinued for ≥2 weeks, enhancing pathogen detection rates.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic discontinuation</subject><subject>Bone SPECT/CT scan</subject><subject>Chronic Disease</subject><subject>Chronic osteomyelitis (COM)</subject><subject>Extremities - diagnostic imaging</subject><subject>Extremities - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Microbiological identification</subject><subject>Middle Aged</subject><subject>Osteomyelitis - diagnosis</subject><subject>Osteomyelitis - diagnostic imaging</subject><subject>Osteomyelitis - microbiology</subject><subject>Pathogen detection</subject><subject>Post-traumatic osteomyelitis (PTO)</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Single Photon Emission Computed Tomography Computed Tomography</subject><subject>Young Adult</subject><issn>0020-1383</issn><issn>1879-0267</issn><issn>1879-0267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2P1DAMjRCIHRb-AUI5cumsnaRfFxCqlg9pJZAYzlGbOpBR2wxJumJ-AX-bjLpw5GT7-T1b9mPsJcIeAaub494txzWc9wKE2iNiq-AR22FTtwWIqn7MdgACCpSNvGLPYjwCYA1SPmVXslWiwgp37HfXL3zwC_GvX267w0134CMlCrPLkD8lN_cTjy5R5NYHPjsT_OD85L87kztupCU5m_Pk_MLdwk8-piKFfp0zZHjWmB_BL5c0JvLzmSaXXOTecvqVAs25ovj2OXti-ynSi4d4zb69vz10H4u7zx8-de_uCiMUpqKVxrYgGzViLSQObTUgKtO31iJBJfoKhFVWlmU_lE1VyqGxoi0NUCsbGEFes9fb3FPwP1eKSc8uGpqmfiG_Ri0RG1VDXZeZqjZqPjnGQFafQn5HOGsEfbFAH_Vmgb5YoDcLsuzVw4Z1mGn8J_r780x4sxEo33nvKOhoHC2GRhfIJD169_8NfwAYC5tk</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Lee, Seung Hoo</creator><creator>Kim, Min Bom</creator><creator>Jeon, Yeong June</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8260-4358</orcidid><orcidid>https://orcid.org/0009-0003-9382-9116</orcidid><orcidid>https://orcid.org/0000-0001-8335-9331</orcidid></search><sort><creationdate>202412</creationdate><title>Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?</title><author>Lee, Seung Hoo ; Kim, Min Bom ; Jeon, Yeong June</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-93cf90384d17231b96b114ca9ff1e062a602f4f355ab58653b8f295c0e9380d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic discontinuation</topic><topic>Bone SPECT/CT scan</topic><topic>Chronic Disease</topic><topic>Chronic osteomyelitis (COM)</topic><topic>Extremities - diagnostic imaging</topic><topic>Extremities - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Microbiological identification</topic><topic>Middle Aged</topic><topic>Osteomyelitis - diagnosis</topic><topic>Osteomyelitis - diagnostic imaging</topic><topic>Osteomyelitis - microbiology</topic><topic>Pathogen detection</topic><topic>Post-traumatic osteomyelitis (PTO)</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Single Photon Emission Computed Tomography Computed Tomography</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Seung Hoo</creatorcontrib><creatorcontrib>Kim, Min Bom</creatorcontrib><creatorcontrib>Jeon, Yeong June</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Injury</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Seung Hoo</au><au>Kim, Min Bom</au><au>Jeon, Yeong June</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?</atitle><jtitle>Injury</jtitle><addtitle>Injury</addtitle><date>2024-12</date><risdate>2024</risdate><volume>55</volume><issue>12</issue><spage>111940</spage><pages>111940-</pages><artnum>111940</artnum><issn>0020-1383</issn><issn>1879-0267</issn><eissn>1879-0267</eissn><abstract>•Bone single photon emission computed tomography/computed tomography (SPECT/CT) can identify infection sites.•The effectiveness of bone SPECT/CT in identifying optimal sites for microbiological sampling remains under-explored.•We investigated whether bone SPECT/CT can effectively guide microbiological sampling in osteomyelitis of the extremities.•The results demonstrated that bone SPECT/CT is a valuable tool for identifying optimal microbiological sampling sites.•Bone SPECT/CT is particularly effective when antibiotics have been discontinued for ≥2 weeks. Accurate microbiological identification is crucial when managing chronic osteomyelitis (COM) and post-traumatic osteomyelitis (PTO). Although bone single photon emission computed tomography/computed tomography (SPECT/CT) has helped in localizing osteomyelitis lesions, its effectiveness in guiding microbiological sampling remains unclear. This study aimed to determine whether bone SPECT/CT can improve microbiological identification rates in COM or PTO of the extremities. From February 2020 to August 2024, 53 patients with suspected COM or PTO in the extremities were retrospectively analyzed. All patients underwent bone SPECT/CT, followed by microbiological sampling during surgery. Tissue samples were taken from the areas of high SPECT/CT uptake or based on intraoperative findings where no uptake was observed. Microorganism identification rates were analyzed, including a sub-group analysis based on antibiotic discontinuation. Of the 53 patients, 42 had positive bone SPECT/CT scan findings, with pathogen identification in 30 patients (71.4 %). In contrast, pathogen identification occurred in one out of twelve patients (9.1 %) with negative findings (odds ratio 25, p&lt; 0.001). Bone SPECT/CT demonstrated a sensitivity of 96.8 % and an overall accuracy of 75.5 %. When antibiotics had been discontinued for ≥2 weeks, the pathogen identification rate increased to 90 %, compared with 50 % for &lt;2 weeks of discontinuation (odds ratio 10.0, p= 0.006). In a sub-group of 30 patients with adequate antibiotic discontinuation duration, a positive bone SPECT/CT scan yielded a pathogen identification rate of 90.1 % (odds ratio 60.0, p= 0.001). Bone SPECT/CT effectively identifies optimal sites for microbiological sampling in COM and PTO of the extremities, particularly when antibiotics have been discontinued for ≥2 weeks, enhancing pathogen detection rates.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>39426161</pmid><doi>10.1016/j.injury.2024.111940</doi><orcidid>https://orcid.org/0000-0001-8260-4358</orcidid><orcidid>https://orcid.org/0009-0003-9382-9116</orcidid><orcidid>https://orcid.org/0000-0001-8335-9331</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0020-1383
ispartof Injury, 2024-12, Vol.55 (12), p.111940, Article 111940
issn 0020-1383
1879-0267
1879-0267
language eng
recordid cdi_proquest_miscellaneous_3118470775
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Adult
Aged
Anti-Bacterial Agents - therapeutic use
Antibiotic discontinuation
Bone SPECT/CT scan
Chronic Disease
Chronic osteomyelitis (COM)
Extremities - diagnostic imaging
Extremities - microbiology
Female
Humans
Male
Microbiological identification
Middle Aged
Osteomyelitis - diagnosis
Osteomyelitis - diagnostic imaging
Osteomyelitis - microbiology
Pathogen detection
Post-traumatic osteomyelitis (PTO)
Retrospective Studies
Sensitivity and Specificity
Single Photon Emission Computed Tomography Computed Tomography
Young Adult
title Can bone SPECT/CT determine optimal sites for microbiological identification in post-traumatic or chronic osteomyelitis of extremities?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A39%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20bone%20SPECT/CT%20determine%20optimal%20sites%20for%20microbiological%20identification%20in%20post-traumatic%20or%20chronic%20osteomyelitis%20of%20extremities?&rft.jtitle=Injury&rft.au=Lee,%20Seung%20Hoo&rft.date=2024-12&rft.volume=55&rft.issue=12&rft.spage=111940&rft.pages=111940-&rft.artnum=111940&rft.issn=0020-1383&rft.eissn=1879-0267&rft_id=info:doi/10.1016/j.injury.2024.111940&rft_dat=%3Cproquest_cross%3E3118470775%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3118470775&rft_id=info:pmid/39426161&rft_els_id=S0020138324006697&rfr_iscdi=true